Abstract

BackgroundPerineural invasion (PNI) is associated with a poor prognosis for cervical cancer and influences surgical strategies. However, a preoperative evaluation that can determine PNI in cervical cancer patients is lacking.MethodsAfter 1:1 propensity score matching, 162 cervical cancer patients with PNI and 162 cervical cancer patients without PNI were included in the training set. Forty-nine eligible patients were enrolled in the validation set. The PNI-positive and PNI-negative groups were compared. Multivariate logistic regression was performed to build the PNI prediction nomogram.ResultsAge [odds ratio (OR), 1.028; 95% confidence interval (CI), 0.999–1.058], adenocarcinoma (OR, 1.169; 95% CI, 0.675–2.028), tumor size (OR, 1.216; 95% CI, 0.927–1.607), neoadjuvant chemotherapy (OR, 0.544; 95% CI, 0.269–1.083), lymph node enlargement (OR, 1.953; 95% CI, 1.086–3.550), deep stromal invasion (OR, 1.639; 95% CI, 0.977–2.742), and full-layer invasion (OR, 5.119; 95% CI, 2.788–9.799) were integrated in the PNI prediction nomogram based on multivariate logistic regression. The PNI prediction nomogram exhibited satisfactory performance, with areas under the curve of 0.763 (95% CI, 0.712–0.815) for the training set and 0.860 (95% CI, 0.758–0.961) for the validation set. Moreover, after reviewing the pathological slides of patients in the validation set, four patients initially diagnosed as PNI-negative were recognized as PNI-positive. All these four patients with false-negative PNI were correctly predicted to be PNI-positive (predicted p > 0.5) by the nomogram, which improved the PNI detection rate.ConclusionThe nomogram has potential to assist clinicians when evaluating the PNI status, reduce misdiagnosis, and optimize surgical strategies for patients with cervical cancer.

Highlights

  • Cervical cancer is the fourth most common cancer among women worldwide [1]

  • Age [odds ratio (OR), 1.028; 95% confidence interval (CI), 0.999–1.058], adenocarcinoma (OR, 1.169; 95% CI, 0.675–2.028), tumor size (OR, 1.216; 95% CI, 0.927–1.607), neoadjuvant chemotherapy (OR, 0.544; 95% CI, 0.269–1.083), lymph node enlargement (OR, 1.953; 95% CI, 1.086–3.550), deep stromal invasion (OR, 1.639; 95% CI, 0.977–2.742), and full-layer invasion (OR, 5.119; 95% CI, 2.788–9.799) were integrated in the Perineural invasion (PNI) prediction nomogram based on multivariate logistic regression

  • Patients were excluded if they had any of the following conditions: cervical stump cancer; histological types except squamous carcinoma, Abbreviations: PNI, perineural invasion; NACT, neoadjuvant chemotherapy; LNE, lymph node enlargement; DSI, deep stromal invasion; FLI, full-layer invasion; Radical hysterectomy (RH), radical hysterectomy; Nerve-sparing radical hysterectomy (NSRH), nerve-sparing radical hysterectomy; MRI: magnetic resonance imaging; Lymph vascular space invasion (LVSI), lymph vascular space invasion; LUSI, lower uterine segment invasion; receiveroperating characteristics (ROC) curve, receiver-operating characteristics curve; AUC, area under the ROC curve; PPV, positive predictive value; NPV, negative predictive value; OR, odds ratio; 95% CI, 95% confidence interval; IQR, interquartile range; CT, computed tomography

Read more

Summary

Introduction

Radical hysterectomy (RH) is a conventional treatment for early-stage cervical cancer that has the advantages of maintaining both ovarian function and sexual function compared with radiotherapy [2, 3]. Perineural invasion (PNI) is reportedly associated with multiple high-risk factors [8, 9] and poor outcomes during early-stage cervical cancer [10, 11]. Pathological examinations have shown that 7.1%–35.1% of patients with early-stage cervical cancer have PNI [8,9,10,11,12,13,14]. Perineural invasion (PNI) is associated with a poor prognosis for cervical cancer and influences surgical strategies. A preoperative evaluation that can determine PNI in cervical cancer patients is lacking

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call